Theranova
San Francisco, US · 1 known investors
TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model. It creates and spins out privately funded medical device companies and has conducted clinical research in the United States, Europe, and South America.
Investors · 1
Non-dilutive funding · 23 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $303K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $223.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $318.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $294.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $309.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $219.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $217.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $224.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $1M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Theranova do?
- TheraNova is a venture studio and incubator that develops medical devices from concept through clinical trials, regulation, and commercialization using a shared R&D model. It creates and spins out privately funded medical device companies and has conducted clinical research in the United States, Europe, and South America.
- Who are Theranova's investors?
- Theranova's investors include Green Park & Golf Ventures.
- Where is Theranova headquartered?
- Theranova is headquartered in San Francisco, US.